Introduction
Methods
Literature search
Inclusion criteria
Exclusion criteria
Evaluation
Outcomes of interest
Results
Appendectomies
References | Study design | Outcome | Further notes | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Design | Study period | n (urgent, robotic) | n (non-urgent) | Primary study objective | Robot | Differentiated urgent vs. non-urgent | Complications conversions | Further outcomes of interest | ||
n (other) | ||||||||||
Cadiére et al. [16] | R-NRNC | 3/1997–2/2001 | 1 | – | Feasibility | Da Vinci | No | No complications | See also cholecystitis | |
145 | No conversions | |||||||||
Kelkar et al. [22] | P-NRNC | 3/2019–4/2019 | 4 | – | Feasibility | Versius | No | No complications | ||
26 | No conversions | |||||||||
Kibar et al. [51] | CR | n.d | 1 | – | – | Da Vinci | Yes | No complications | Appendicovesical fistula | |
– | No conversions | |||||||||
Mittal et al. [21] | P-NRNC | n.d | 22 | – | Feasibility/usefulness | FreeHand RCM | No | No complications | Liberation of the surgical assistant | |
– | No conversions | |||||||||
Ohmura et al. [14] | R-NRC | 12/2014–3/2017 | 163 | 3 | feasibility | Soloassist RCM | No | “No device-related complications” | Liberation of the surgical assistant | See also cholecystitis and hollow organs |
783 | No conversions | |||||||||
Yi et al. [12] | CS | 3/2014 | 2 | – | Feasibility | Micro Hand S | Yes | No complications | See also hollow organs | |
1 | No conversions | |||||||||
Yi et al. [13] | CS | 4/2014–5/2014 | 3 | 1 | Feasibility | Micro Hand S | No | No complications | 2 patients withdrawn | See also cholecystitis and hollow organs |
6 | No conversions |
Cholecystectomies
References | Study design | Outcome | Further notes | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Design | Study period | n (urgent, robotic) | n (non-urgent) | Primary study objective | Robot | Differentiated urgent vs. non-urgent | Complications conversions | Further outcomes of interest | ||
n (other) | ||||||||||
Ayloo et al. [52] | R-NRC | 9/2005–6/2012 | 45 | 134 | MIRC vs. MILC | Da Vinci | No | 1.7% CD ≥ 3; 1.7% CD < 3” | 3 conversions in MILC; OT longer in MIRC | |
147 | no conversions | |||||||||
Balachandran et al. [53] | R-NRC | 10/2011–7/2014 | 76 | 339 | SIRC vs. MILC | Da Vinci | No | 1% ileus 0.2% bile leakage | 6.5% hernias in SIRC LOS shorter SIRC | All performed by 1 surgeon |
263 | 2.9% to MILC, 3.2% to open | |||||||||
Bibi et al. [33] | R-NRNC | 6/2012–1/2013 | 31 | 71 | Safety of SIRC | Da Vinci | No | 4% CD < 3 | 50% of conversions due to inflammation | |
– | 3.9% conversions | |||||||||
Buzad et al. [17] | P-NRC | 1/2012–5/2012 | 2 | 18 | SIRC vs. SILC | Da Vinci | No | No complications | No differences in OT and costs | SILC reviewed retrospectively |
10 | No conversion | |||||||||
Cadiére et al. [16] | R-NRNC | 3/1997–2/2001 | 4 | 44 | Feasibility | Da Vinci | No | 25% (n = 1) CD 2 | See also appendicitis | |
98 | no conversions | |||||||||
Chung et al. [29] | R -NRC | 8/2013–1/2015 | 7 | 63 | SILC vs. MILC | Da Vinci | No | n.d | 2.8% 30 d readmission | |
70 | 1.4% conversion to open | |||||||||
Daskalaki et al. [54] | R-NRNC | 7/2011–2/2013 | 28 | 156 | ICG Cholangio-graphy | Da Vinci | No | 1% CD ≥ 3; 2.2% CD < 3 | cholangiography > 94% | |
– | no conversions | |||||||||
Gangemi et al. [28] | R- NRC | 2008–2015 | 130 | 546 | Risk factors for conversion | n.d | N.d | n.d | ||
289 | 0.15% (n = 1) conversions | |||||||||
Giulianotti et al. [15] | R-NRNC | 10/2000–11/2002 | 7 | 45 | Descriptive; RC vs. LC | Da Vinci | No | 1.9% (n = 1) complications n.d | ||
123 | 1.9% (n = 1) conversions | |||||||||
Gonzalez et al. [55] | R-NRC | 1/2012–9/2012 | 20 | 146 | SILC vs. SIRC vs. SPIDER | Da Vinci | No | 1.2% CD ≥ 3; 0.6% CD < 3 | OT for SIRC longer than SILC/SPIDER | |
335 | No (3 additional incisions) | |||||||||
Honaker et al. [56] | R-NRC | 3/2013–2/2014 | 1 | 17 | MIRC vs. MILC | Da Vinci | No | No complications | LOS shorter MIRC | |
40 | No conversions | |||||||||
Jeong Jang et al. [57] | R-NRNC | 4/2019–8/2020 | 2 (5) | 72 (69) | Feasibility of SIRC | Da Vinci | No | 1.35% CD 1 | 3 acute cholecystitis diagnosed intraoperatively | |
– | No conversions | |||||||||
Kalteis et al. [58] | R-NRC | 4/2002–11/2004 | 20 | 52 | Safety and effectiveness | AESOP | No | 1.4% CD < 3 | Liberation of the surgical assistant | |
72 | No conversions | |||||||||
Konstantinidis et al. [18] | P-NRNC | 3/2011–7/2011 | 4 | 41 | Feasibility and effectiveness | Da Vinci | No | 2.2.% CD 3b, 5.3% < CD 3 | 20% intraoperative gallbladder-ruptures | |
– | No conversions | |||||||||
Kornprat et al. [19] | P-NRC | 2001–2006 | 2 | 18 | MIRC vs. MILC | Zeus | No | No complications | OT longer in MIRC | |
26 | No conversions | |||||||||
Kubat et al. [23] | R-NRC | 5/2012–8/2013 | 74 | 76 | Urgent vs. non-urgent MIRC | Da Vinci | Yes | 12% complications in urgent, incl. 1.5% (n = 1) BD injury | LOS longer in urgent, overall complications + SSI no differences | |
– | 1.5% (n = 1) conversions | |||||||||
Kulaylat et al. [36] | R-NRC | 1/2015–12/2018 | 10 | 69 | SIRC/MIRC vs. SILC/MILC | Da Vinci | No | “No differences in complications” | OT longer in robotic, costs higher in robotic | Pediatric patients |
220 | No conversions | |||||||||
Li et al. [42] | R-NRC | 8/2013–12/2015 | 17 | 61 | Safety, resources SIRC vs. MILC | Da Vinci | No | 3.8% < CD 3 (20% in MILC) | 1.9% conversion rate in MILC | OT, LOS and costs higher in SIRC |
367 | No conversions | |||||||||
Mattei et al. [59] | R-NRNC | 2013–? | 1 | 19 | Feasibility in pediatric patients | Da Vinci | No | 20% seromas (CD < 3) | OT longer, LOS shorter | |
– | No conversions | |||||||||
Ohmura et al. [14] | R-NRC | 12/2014–3/2017 | 101 | 172 | Feasibility | Soloassist RCM | No | “No device-related complications” | LOS shorter; liberation of surgical assistant | See also appendicitis and hollow organs |
848 | No conversions | |||||||||
Rosales-Velderrain et al. [60] | P-NRNC | 3/2013–5/2015 | 4 | 10 | Safety, feasibility in pediatric patients | Da Vinci | No | 7% (n = 1) seroma | ||
– | No conversions | |||||||||
Schertz et al. [35] | R-NRC | 8/2013–4/2018 | 3/6 | 101/99 | SIRC vs. MIRC | Da Vinci | No | 1 enterotomy (MIRC), 2.9% hernias (SIRC) | OT, LOS in SIRC shorter | |
– | Excluded | |||||||||
Su et al. [61] | R-NRC | 2/2014–9/2015 | 10 | 41 | SIRC vs. SILC | Da Vinci | No | No complications | OT in urgent longer Pain lower in SIRC | |
63 | No conversions | |||||||||
Svoboda et al. [20] | P-NRC | 11/2012–2/2014 | 159 | 112 | SIRC in BMI ≥ 30 vs. < 30 | Da Vinci | No | 0.9% (n = 1), incisional hernia | OT longer in obese patients | Inconclusive data |
– | no conversions | |||||||||
Tao et al. [62] | R- NRC | 1/2006–2/2020 | 13 | 161 | MILC vs. MIRC | Da Vinci | No | 12.3% overall in RC | RC vs. LC CD 1 > , CD 2 < , CD 3 equal, no CD IV | All acute cholecystitis diagnosed intraoperatively |
441 | No conversion | |||||||||
Vidovszky et al. [34] | P-NRNC | 1/2012–1/2013 | 13 | 82 | apPlicability of SIRC | Da Vinci | No | 4.2% CD 3; 2.1% < CD 3 | One disruption of DC 4 technical problems | 5 inflammations diagnosed intraoperatively |
– | 8.4%; 1 due to inflammation | |||||||||
Case Series Case Reports | CS/CR | 2001–2021 | 11 | Feasibility | Da Vinci (3), Microhand S (1) | No | No complications | |||
No conversions |
Gastrointestinal procedures
References | Study design | Outcome | Further notes | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Design | Study period | n (urgent, robotic) | n (non-urgent) | primary study objective | Robot | Differentiated urgent vs. non-urgent | Complications conversions | Further outcomes of interest | ||
n (other) | ||||||||||
Anderson et al. [24] | R-NRC | 2/2015–2/2017 | 6 | – | Urgent subtotal colectomy: robotic vs. Laparoscopic | Da Vinci | Yes | 20% (n = 1) CD 2 | OT longer in robotic | 2 dockings |
13 | No conversions | |||||||||
Beltzer et al. [37] | R-NRC | 10/2013–11/2018 | 2 | 58 | Diverticular disease: robotic vs. Laparoscopic | Da Vinci | No | 15% cd ≥ 3; 15% < 3 | Length of postop ileus in robotic group shorter | Urgency unclear, used: CDD Type 2c |
46 | 1.7% (n = 1) conversions | |||||||||
Felli et al. [63] | CR | n.d | 1 | – | Hemicolectomy for hemorrhagic cancer | Da Vinci | Yes | No complications | Double-barreled ileocolostomy; oncologic resection | |
– | No conversion | |||||||||
Guerra et al. [64] | CR | n.d | 1 | – | Acute large bowel malignant obstruction | Da Vinci | Yes | No complications | Oncological resection of a splenic flexure tumor | |
– | No conversions | |||||||||
3 CR | 2019–2020 | 3 | – | 3 colon resections | Da Vinci | Yes | No complications | All with hand sutured anastomosis | 3 video vignettes | |
– | No conversions | |||||||||
Ohmura et al. [14] | R-NRC | 12/2014–3/2017 | 16 | – | Feasibility | Soloassist RCM | No | “No device-related complications” | LOS shorter liberation of surgical assistant | See also appendicitis and cholecystitis |
933 | No conversions | |||||||||
Pedraza et al. [65] | CR | n.d | 1 | – | Iatrogenic colonic perforation; | Da Vinci | Yes | No complications | Primary repair | |
– | No conversions | |||||||||
Robinson et al. [38] | R-NRC | 2015–2019 | 24 | – | Perforated gastrojejunal ulcera | Da Vinci | Yes | 8.3%, median cd-score 2.2 | Complications similar to laparoscopic group | Robotic vs. laparoscopic; higher costs in robotic |
20 | No conversions | |||||||||
Sudan et al. [66] | CR | n.d | 1 | – | Duodenal stump insufficiency | Da Vinci | Yes | No complications | 5 d after BPD-DS, biliary peritonitis | |
– | No conversions | |||||||||
Sun et al. [67] | CR | 3/2014 | 1 | – | Gastric perforations | Microhand S | Yes | No complications | ||
– | No conversions | |||||||||
Yi et al. [12] | CS | 3/2014 | 1 | – | Repair of gastric perforation | Microhand S | No | No complications | See also appendicitis and cholecystitis | |
1 | No conversions | |||||||||
Yi et al. [13] | CS | 4/2014–5/2014 | 1 | – | Repair of gastric perforation | Microhand S | No | No complications | Withdrawal of 2 patients | See also appendicitis and cholecystitis |
7 | No conversions |
Hernias/miscellaneous
References | Study design | Outcome | Further notes | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Design | Study period | n (urgent, robotic) | n (non-urgent) | Primary study objective | Robot | Differentiated urgent vs. non-urgent | Complications | Further outcomes of interest | ||
n (control) | Conversions | |||||||||
Bou-Ayash et al. [25] | R-NRNC | 2/2013–5/2020 | 19 | – | Incarcerated inguinal hernia | Da Vinci | Yes | 5.3% CD IVa (n = 1; hypercarbia); 10.6% CD < 3 | ||
– | No conversions | |||||||||
Cubas et al. [68] | CR | n.d | 1 | – | Incarcerated morgagni hernia | Da Vinci | Yes | No complication | ||
– | No conversion | |||||||||
Ceccarelli et al. [69] | CS | 12/2009–12/2019 | 3 | – | Strangulated hiatal hernias | Da Vinci | Yes | 33% (n = 1) CD 3 | ||
2 lap | No conversions | |||||||||
Giulianotti et al. [15] | R-NRNC | 10/2000–11/2002 | 1 | 192 | Feasibility; here: posttraumatic spleen hematoma | Da Vinci | No | No complications | One CD V in non-urgent patients | |
– | No conversions | |||||||||
Hosein et al. [27] | database query | 2015–2017 | 131 | 704 | Hiatal hernia repair: robotic vs. Lap. Vs. Open | n.d | No | 2% overall complications; 0.1% (n = 1) CD V | More urgent and severe ill cases in open; robotic less complication than lap/open | |
1488 open 6774 lap | n.d | |||||||||
Muhonen et al. [70] | CS | n.d | 1 | – | Incarcerated paraduodenal hernia | Da Vinci | Yes | No complications | ||
2 lap | No conversions | |||||||||
Muysoms et al. [41] | R-NRC | 1/2016–12/2019 | 8 | 396 | Robotic vs. Lap. Inguinal hernia | Da Vinci | No | 3.5% CD II, 0.2% CD IIIb | Shorter hospital stay, higher costs in robotic group | |
272 | No conversions | |||||||||
Kudsi et al. [40] | R-NRC | 2013–2019 | 34 | – | Incarcerated hernia robotic vs. Open | Da Vinci | Yes | 23.3% < CD 3; 13.3% ≥ CD 3; 3.2% recurrence | OT shorter in open, more CD ≥ 3 in open, more SSI in open | IPOM & TAPP |
43 | No conversions | |||||||||
Smith et al. [71] | CR | n.d | 1 | – | Incarcerated inguinal hernia | Da Vinci | Yes | No complications | TAPP | |
– | No conversion |